CYTOKINETICS INCORPOR

Cytokinetics Presents New Data at CMR 2024 From FOREST-HCM, the Open Label Extension Clinical Trial of Aficamten

25 Jan 2024 06:30:00 By Nasdaq GlobeNewswire

Cytokinetics Announces New Data From FOREST-HCM to be Presented at CMR 2024

18 Jan 2024 12:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: CYTOKINETICS INCORPORATED - COMMON STOCK

08 Jan 2024 12:11:15 By NetDania Notify

NetDania - New 12 months High: CYTOKINETICS INCORPORATED - COMMON STOCK

05 Jan 2024 12:03:16 By NetDania Notify

NetDania - New 12 months High: CYTOKINETICS INCORPORATED - COMMON STOCK

04 Jan 2024 10:15:57 By NetDania Notify

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 Jan 2024 15:00:00 By Nasdaq GlobeNewswire

Cytokinetics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

02 Jan 2024 15:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: CYTOKINETICS INCORPORATED - COMMON STOCK

02 Jan 2024 09:11:41 By NetDania Notify

NetDania - New 12 months High: CYTOKINETICS INCORPORATED - COMMON STOCK

29 Dec 2023 10:14:15 By NetDania Notify

NetDania - New 12 months High: CYTOKINETICS INCORPORATED - COMMON STOCK

28 Dec 2023 08:45:29 By NetDania Notify

NetDania - New 12 months High: CYTOKINETICS INCORPORATED - COMMON STOCK

27 Dec 2023 08:45:16 By NetDania Notify

Cytokinetics Announces Positive Results From SEQUOIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy

27 Dec 2023 06:30:00 By Nasdaq GlobeNewswire

Cytokinetics to Host Investor Call on December 27 to Discuss the Topline Results from SEQUOIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Obstructive Hypertrophic Cardiomyopathy

26 Dec 2023 15:00:11 By Nasdaq GlobeNewswire

Cytokinetics Presents Results From COURAGE-ALS at the 34th International Symposium on ALS/MND

07 Dec 2023 06:30:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 Dec 2023 15:00:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Five Presentations at the 34th International Symposium on ALS/MND

29 Nov 2023 15:00:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

03 Nov 2023 15:00:00 By Nasdaq GlobeNewswire

Cytokinetics Reports Third Quarter 2023 Financial Results

02 Nov 2023 15:00:00 By Nasdaq GlobeNewswire

Cytokinetics to Participate in Upcoming Investor Conferences

01 Nov 2023 15:00:00 By Nasdaq GlobeNewswire

Cytokinetics to Announce Third Quarter Results on November 2, 2023

23 Oct 2023 15:00:00 By Nasdaq GlobeNewswire